Description: CJC‑1295 with DAC is a synthetic growth‑hormone‑releasing hormone (GHRH) analogue modified with a Drug‑Affinity Complex (DAC) to prolong plasma half‑life and sustain stimulation of pituitary growth‑hormone release, resulting in elevated circulating GH and downstream IGF‑1 in preclinical and clinical studies.
Intended use: RESEARCH CHEMICAL — for in vitro testing and laboratory experimentation by qualified professionals only. Not for human or animal administration. This product is not a drug, food, or cosmetic and must not be misbranded, misused, or mislabeled.
